Some figures reveal far more than they seem. In 2025, the teams at Ace Alzheimer Center Barcelona contributed to 52 scientific publications. Behind this number are questions that arise in the clinic, hours of analysis in laboratories, meetings with international teams, and, above all, people who trust research as a path toward progress.
The full compilation of these articles is now available on our website.
Research is how we transform clinical experience into knowledge — and knowledge into concrete improvements in the diagnosis and management of Alzheimer’s disease, dementias, and other neurodegenerative disorders.
Presence in Leading International Journals
Throughout 2025, studies involving Ace have been published in leading scientific journals such as Nature Medicine, Nature Genetics, Nature Aging, JAMA Psychiatry, Brain, and Alzheimer’s & Dementia, among others.
Beyond prestige, publishing in these journals means that the research has undergone rigorous peer review and that the findings contribute to shaping international knowledge on neurodegenerative diseases. It is a way of participating in the global scientific conversation and contributing evidence generated from clinical practice and applied research.
What Do These 52 Articles Tell Us?
The research areas are diverse, yet they share a common goal: to better understand the disease in order to act earlier and more effectively.
This year’s publications include studies on:
-
New blood and cerebrospinal fluid biomarkers that may enable earlier and more accessible diagnosis.
-
Genetic factors influencing risk and progression of Alzheimer’s disease.
-
Neuroimaging and the progression of cognitive decline.
-
Clinical trials and emerging therapeutic approaches.
-
Digital tools and innovative technologies applied to cognitive monitoring.
Each article represents one more piece in a complex field, where advances are rarely dramatic or immediate, but are cumulative and essential.
Research Connected to People
In the field of neurodegenerative diseases, progress requires persistence and collaboration. The 52 publications of 2025 are the result of that collective effort: professionals from multiple disciplines, international partnerships, and individuals who participate in studies with the intention of contributing to a better future.
Making this compilation publicly available is not only a matter of transparency; it is our way of sharing our commitment to rigorous, collaborative, and impact-driven research.
Because, ultimately, research is not just about publishing — it is about generating knowledge that helps change the course of disease and improve people’s lives.
Explore the full compilation of Ace’s 2025 scientific publications here.
